𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of Second-Trimester Maternal Serum Screening on Prenatal Diagnosis of Down Syndrome and the use of Amniocentesis in the Taiwanese Population

✍ Scribed by Chih-Ping Chen; Chen-Ju Lin; Wayseen Wang

Book ID
117697176
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
67 KB
Volume
44
Category
Article
ISSN
1028-4559

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Second-trimester prenatal screening for
Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome
✍ Kevin Spencer πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 60 KB πŸ‘ 3 views

In a group of 26 524 control pregnancies and a group of 3728 pregnancies affected by one or more of the pregnancy complications of low birthweight, intra-uterine growth restriction (IUGR), preterm delivery and stillbirth, I have compared the relative risk of occurrence of these complications in preg

Maternal serum prostate-specific antigen
Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy
✍ N. J. Wald; A. K. Hackshaw; E. P. Diamandis; D. N. Melegos πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 3 views

It has been suggested that high levels of maternal serum prostate-specific (PSA) may be associated with fetal Down syndrome. We retrieved stored blood samples from 102 singleton Down syndrome pregnancies at 8-14 weeks' gestation and 99 at 15-22 weeks' gestation, together with samples from five unaff